The launch of the Shanghai Institute for Advanced Immunochemical Studies marks China's first attempt to establish a center of antibody research on par with research centers in the U.S. and Europe. SIIS will identify targets and develop antibodies to treat cancer as well as infectious, autoimmune and metabolic diseases.